Here are the DEF 14A proxy statements from Mountain Crest Acq V RTS (MCAGR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow MCAGR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MCAGR filings page.
Mountain Crest Acquisition Corp. V (MCAG) asks stockholders to amend its charter, extending its initial business-combination deadline from November 16, 2026, to May 16, 2027, if approved and implemented. The November 10, 2026, virtual meeting also includes a proposal to authorize adjournment for further proxy solicitation; it is not the vote on the CubeBio transaction. The Board may abandon the amendment even after approval.
Management says it cannot close its proposed combination with CubeBio Co., Ltd. before the current deadline but believes it can close before the extended date. A separate transaction vote is scheduled for November 11, 2026; closing is subject to stockholder approval, listing approval for PubCo ordinary shares on Nasdaq or another mutually agreed U.S. exchange, and other conditions.
The Trust Account held approximately $861,864 as of September 14, 2026, and the estimated redemption price was approximately $11.95 per public share before estimated taxes. Public holders may elect redemption regardless of how they vote and must tender shares by November 6, 2026. If the extension is not implemented and no combination is completed by November 16, 2026, the company says it would wind up and redeem 100% of outstanding public shares.